Induction of Cross-Clade Antibody and T-Cell Responses by a Modified Vaccinia Virus Ankara-Based Influenza A(H5N1) Vaccine in a Randomized Phase 1/2a Clinical Trial.
de Vries RD, Altenburg AF, Nieuwkoop NJ, de Bruin E, van Trierum SE, Pronk MR, Lamers MM, Richard M, Nieuwenhuijse DF, Koopmans MPG, Kreijtz JHCM, Fouchier RAM, Osterhaus ADME, Sutter G, Rimmelzwaan GF.
de Vries RD, et al. Among authors: altenburg af.
J Infect Dis. 2018 Jul 13;218(4):614-623. doi: 10.1093/infdis/jiy214.
J Infect Dis. 2018.
PMID: 29912453
Free PMC article.
Clinical Trial.